Marina Valente
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marina Valente has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Federico Marchesi
Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy
6 shared publications - Giorgio Dalmonte
Unit of General Surgery, Parma University Hospital, Parma, Italy
5 shared publications - Matteo Riccò
Servizio di Prevenzione e Sicurezza Negli Ambienti di Lavoro (SPSAL), AUSL-IRCCS di Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy
5 shared publications - Francesco Tartamella
Unit of General Surgery, Parma University Hospital, Parma, Italy
4 shared publications - Paolo Del Rio
Department of General Surgery University Hospital Parma Parma Italy
3 shared publications - Alfredo Annicchiarico
Department of Medicine and Surgery, University of Parma, Parma, Italy
2 shared publications
Latest Publications
- 19 June 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (9) , 3506-3508
Can You Believe It? How to Deal with an Intragastric Balloon Migration in the Pleural Cavity
- 19 June 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (9) , 3506-3508
Can You Believe It? How to Deal with an Intragastric Balloon Migration in the Pleural Cavity
- 28 October 2023
- Published by Springer Nature in Obesity Surgery
- Vol. 33 (12) , 4049-4057
Bariatric Surgery and COVID-19: a Change of Perspective in a New Phase of the Pandemic
Purpose The protective role of bariatric surgery (BS) against COVID-19 has been reported by several studies, showing, in the first pandemic waves, better outcome of the infection in patients that had undergone BS. With the virus progressive endemicity, BS benefits on COVID-19 clinical course could appear less evident, while COVID-19 effects on BS outcomes must be investigated. In this national multicentric cross-sectional study, we compared COVID-19 incidence and clinical course between a cohort of patients that had undergone BS (OP) and a cohort of candidates to BS (WS); moreover, we analyzed BS outcomes based on SARS-CoV-2 positivity/negativity. Methods From June to December 2021, 522 patients from five Italian referral centers were administered an 87-item telephonic questionnaire completing the analysis of electronic medical records. Demographics, COVID-19 “tested” incidence, suggestive symptoms and clinical outcome parameters of OP and WS were compared. BS outcomes parameters were compared between OP that developed the disease or not. Results COVID-19 incidence was the same in OP and WS, while symptoms and clinical course seemed milder in OP, with no data individually reaching statistical significance. OP who developed SARS-CoV-2 infection had higher excess weight loss than negative OP (66.8% ± 22.1 vs. 57.7% ± 22.8, p = 0.029). Positive OP had had gastric-bypass (RYGB/OAGB) more frequently than negative ones (38.4% vs. 18.2%, p = 0.025). Conclusion With the disease becoming endemic, BS protective role against COVID-19 seems clinically less relevant. BS outcomes can be affected by COVID-19, thus imposing careful follow-up for positive patients, especially if undergoing gastric-bypass. Graphical Abstract
- 28 October 2023
- Published by Springer Nature in Obesity Surgery
- Vol. 33 (12) , 4049-4057
Bariatric Surgery and COVID-19: a Change of Perspective in a New Phase of the Pandemic
Purpose The protective role of bariatric surgery (BS) against COVID-19 has been reported by several studies, showing, in the first pandemic waves, better outcome of the infection in patients that had undergone BS. With the virus progressive endemicity, BS benefits on COVID-19 clinical course could appear less evident, while COVID-19 effects on BS outcomes must be investigated. In this national multicentric cross-sectional study, we compared COVID-19 incidence and clinical course between a cohort of patients that had undergone BS (OP) and a cohort of candidates to BS (WS); moreover, we analyzed BS outcomes based on SARS-CoV-2 positivity/negativity. Methods From June to December 2021, 522 patients from five Italian referral centers were administered an 87-item telephonic questionnaire completing the analysis of electronic medical records. Demographics, COVID-19 “tested” incidence, suggestive symptoms and clinical outcome parameters of OP and WS were compared. BS outcomes parameters were compared between OP that developed the disease or not. Results COVID-19 incidence was the same in OP and WS, while symptoms and clinical course seemed milder in OP, with no data individually reaching statistical significance. OP who developed SARS-CoV-2 infection had higher excess weight loss than negative OP (66.8% ± 22.1 vs. 57.7% ± 22.8, p = 0.029). Positive OP had had gastric-bypass (RYGB/OAGB) more frequently than negative ones (38.4% vs. 18.2%, p = 0.025). Conclusion With the disease becoming endemic, BS protective role against COVID-19 seems clinically less relevant. BS outcomes can be affected by COVID-19, thus imposing careful follow-up for positive patients, especially if undergoing gastric-bypass. Graphical Abstract
- 16 August 2022
- Published by SAGE Publications in Angiology
- Vol. 74 (4) , 397-398
Artificial Intelligence Is the Future of Surgical Departments … Are We Ready?
- 16 August 2022
- Published by SAGE Publications in Angiology
- Vol. 74 (4) , 397-398
Artificial Intelligence Is the Future of Surgical Departments … Are We Ready?
- Open Access
- 2 September 2021
- Vol. 92 (4) , e2021324
Hantavirus infections in Italy: not reported doesn’t mean inexistent
Hantaviruses can cause serious human diseases including hemorrhagic fever with renal syndrome (HFRS) and Hantavirus Cardiopulmonary Syndrome (HCPS). European Hantavirus are usually associated with HFRS, and their geographical distribution mirrors the ecology of reservoir host species. Epidemiology of HFRS is well-studied in Western Europe, but data from Italy are fragmentary. We searched into two different databases (PubMed and EMBASE), focusing on studies reporting the prevalence of Hantaviruses in Italy. Data were extracted using a standardized assessment form, and results of the analyses were systematically reported, summarized and compared. We identified a total of 18 articles, including 12 reports (total population: 5,336 subjects, 1981-2019) and 6 case reports (1984-2019). In total, 200 subjects exhibited some degree of seropositivity, with a pooled seroprevalence of 1.7% (95% confidence interval 0.7%-4.0%) in the general population. Higher occurrence was reported in selected subgroups, i.e. acute (28.7%, 95%CI 22.1-36.2) and chronic (6.6%, 95%CI 4.7-9.1) renal failure, forestry workers (3.0%, 95%CI 1.4-6.5, actual range 0.0 to 10.8%). In the last decade, no human cases of hantavirus infection have been officially reported in Italy. However, our analysis stresses the actual occurrence of Hantavirus among general population and in selected population groups. Further studies on hantavirus infection rates in reservoir host species (rodents, shrews, and bats) and virus transmission to humans are needed to prevent outbreaks in the future.
- 2 September 2021
- Vol. 92 (4) , e2021324
Open AccessHantavirus infections in Italy: not reported doesn’t mean inexistent
Hantaviruses can cause serious human diseases including hemorrhagic fever with renal syndrome (HFRS) and Hantavirus Cardiopulmonary Syndrome (HCPS). European Hantavirus are usually associated with HFRS, and their geographical distribution mirrors the ecology of reservoir host species. Epidemiology of HFRS is well-studied in Western Europe, but data from Italy are fragmentary. We searched into two different databases (PubMed and EMBASE), focusing on studies reporting the prevalence of Hantaviruses in Italy. Data were extracted using a standardized assessment form, and results of the analyses were systematically reported, summarized and compared. We identified a total of 18 articles, including 12 reports (total population: 5,336 subjects, 1981-2019) and 6 case reports (1984-2019). In total, 200 subjects exhibited some degree of seropositivity, with a pooled seroprevalence of 1.7% (95% confidence interval 0.7%-4.0%) in the general population. Higher occurrence was reported in selected subgroups, i.e. acute (28.7%, 95%CI 22.1-36.2) and chronic (6.6%, 95%CI 4.7-9.1) renal failure, forestry workers (3.0%, 95%CI 1.4-6.5, actual range 0.0 to 10.8%). In the last decade, no human cases of hantavirus infection have been officially reported in Italy. However, our analysis stresses the actual occurrence of Hantavirus among general population and in selected population groups. Further studies on hantavirus infection rates in reservoir host species (rodents, shrews, and bats) and virus transmission to humans are needed to prevent outbreaks in the future.
- 31 March 2021
- Published by Springer Nature in Obesity Surgery
- Vol. 31 (7) , 3341-3346
Effects of Bariatric Surgery on Influenza-Like Illness: a Two-Center Cross-sectional Study
- 31 March 2021
- Published by Springer Nature in Obesity Surgery
- Vol. 31 (7) , 3341-3346
Effects of Bariatric Surgery on Influenza-Like Illness: a Two-Center Cross-sectional Study
- 8 January 2021
- Published by Springer Nature in Obesity Surgery
- Vol. 31 (6) , 2477-2488
Effects of Bariatric Surgery on COVID-19: a Multicentric Study from a High Incidence Area
Introduction The favorable effects of bariatric surgery (BS) on overall pulmonary function and obesity-related comorbidities could influence SARS-CoV-2 clinical expression. This has been investigated comparing COVID-19 incidence and clinical course between a cohort of patients submitted to BS and a cohort of candidates for BS during the spring outbreak in Italy. Materials and Methods From April to August 2020, 594 patients from 6 major bariatric centers in Emilia-Romagna were administered an 87-item telephonic questionnaire. Demographics, COVID-19 incidence, suggestive symptoms, and clinical outcome parameters of operated patients and candidates to BS were compared. The incidence of symptomatic COVID-19 was assessed including the clinical definition of probable case, according to World Health Organization criteria. Results Three hundred fifty-three operated patients (Op) and 169 candidates for BS (C) were finally included in the statistical analysis. While COVID-19 incidence confirmed by laboratory tests was similar in the two groups (5.7% vs 5.9%), lower incidence of most of COVID-19-related symptoms, such as anosmia (p: 0.046), dysgeusia (p: 0.049), fever with rapid onset (p: 0.046) were recorded among Op patients, resulting in a lower rate of probable cases (14.4% vs 23.7%; p: 0.009). Hospitalization was more frequent in C patients (2.4% vs 0.3%, p: 0.02). One death in each group was reported (0.3% vs 0.6%). Previous pneumonia and malignancies resulted to be associated with symptomatic COVID-19 at univariate and multivariate analysis. Conclusion Patients submitted to BS seem to develop less severe SARS-CoV-2 infection than subjects suffering from obesity.
- 8 January 2021
- Published by Springer Nature in Obesity Surgery
- Vol. 31 (6) , 2477-2488
Effects of Bariatric Surgery on COVID-19: a Multicentric Study from a High Incidence Area
Introduction The favorable effects of bariatric surgery (BS) on overall pulmonary function and obesity-related comorbidities could influence SARS-CoV-2 clinical expression. This has been investigated comparing COVID-19 incidence and clinical course between a cohort of patients submitted to BS and a cohort of candidates for BS during the spring outbreak in Italy. Materials and Methods From April to August 2020, 594 patients from 6 major bariatric centers in Emilia-Romagna were administered an 87-item telephonic questionnaire. Demographics, COVID-19 incidence, suggestive symptoms, and clinical outcome parameters of operated patients and candidates to BS were compared. The incidence of symptomatic COVID-19 was assessed including the clinical definition of probable case, according to World Health Organization criteria. Results Three hundred fifty-three operated patients (Op) and 169 candidates for BS (C) were finally included in the statistical analysis. While COVID-19 incidence confirmed by laboratory tests was similar in the two groups (5.7% vs 5.9%), lower incidence of most of COVID-19-related symptoms, such as anosmia (p: 0.046), dysgeusia (p: 0.049), fever with rapid onset (p: 0.046) were recorded among Op patients, resulting in a lower rate of probable cases (14.4% vs 23.7%; p: 0.009). Hospitalization was more frequent in C patients (2.4% vs 0.3%, p: 0.02). One death in each group was reported (0.3% vs 0.6%). Previous pneumonia and malignancies resulted to be associated with symptomatic COVID-19 at univariate and multivariate analysis. Conclusion Patients submitted to BS seem to develop less severe SARS-CoV-2 infection than subjects suffering from obesity.
- 22 November 2020
- Published by Wiley in Colorectal Disease
- Vol. 23 (2) , 557-559
Laparoscopic subtotal colectomy with antiperistaltic caecorectal anastomosis in severe slow transit constipation — a video vignette
Slow transit constipation is a severe form of chronic constipation characterized by prolonged colonic transit time which affects greatly the patients’ quality of life. Usually, dietary changes, increased fiber intake and laxatives represent the first medical approach, nevertheless a small number of patients are not responsive to nutritional and pharmacological therapy: for those patients only, a surgical approach can be considered. A subtotal colectomy with antiperistaltic cecorectal anastomosis offers advantages in terms of absorption of water, electrolytes, bile salts and vitamin B12 obtained by preserving ileocecal junction, terminal ileum and caecum. We present our minimally‐invasive surgical technique for subtotal colectomy with antiperistaltic cecorectal anastomosis. The post‐operative course was smooth. Eight months after the intervention the patient reported 2‐3 bowel‐movement per day and semi‐liquid faeces. The technique explained allows for a feasible minimally invasive subtotal colectomy with antiperistaltic cecorectal anastomosis.
- 22 November 2020
- Published by Wiley in Colorectal Disease
- Vol. 23 (2) , 557-559
Laparoscopic subtotal colectomy with antiperistaltic caecorectal anastomosis in severe slow transit constipation — a video vignette
Slow transit constipation is a severe form of chronic constipation characterized by prolonged colonic transit time which affects greatly the patients’ quality of life. Usually, dietary changes, increased fiber intake and laxatives represent the first medical approach, nevertheless a small number of patients are not responsive to nutritional and pharmacological therapy: for those patients only, a surgical approach can be considered. A subtotal colectomy with antiperistaltic cecorectal anastomosis offers advantages in terms of absorption of water, electrolytes, bile salts and vitamin B12 obtained by preserving ileocecal junction, terminal ileum and caecum. We present our minimally‐invasive surgical technique for subtotal colectomy with antiperistaltic cecorectal anastomosis. The post‐operative course was smooth. Eight months after the intervention the patient reported 2‐3 bowel‐movement per day and semi‐liquid faeces. The technique explained allows for a feasible minimally invasive subtotal colectomy with antiperistaltic cecorectal anastomosis.